Profile picture

Doctor Marc Vanderheyden

Cardiovascular Research Center Aalst, Aalst (Belgium)
Follow
Logo ESC

Contributor content

Myocardial work predicts left ventricular dysfunction following transcatheter aortic valve replacement in patients with aortic valve stenosis
Presentation
Myocardial work predicts left ventricular dysfunction following transcatheter aortic valve replacement in patients with aortic valve stenosis
Impact of eGFR slope upon mortality in a real world heart failure cohort
Presentation
Impact of eGFR slope upon mortality in a real world heart failure cohort
Detecting transthyretin amyloid cardiomyopathy in a real-world heart failure population: automated data extraction from electronic health records using natural language processing
Presentation
Detecting transthyretin amyloid cardiomyopathy in a real-world heart failure population: automated data extraction from electronic health records using natural language processing
T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients
Presentation
T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients
Real-world eligibility for dapagliflozin in unselected heart failure patients: data from the CORDIS-HF registry
Presentation
Real-world eligibility for dapagliflozin in unselected heart failure patients: data from the CORDIS-HF registry
Functional mitral regurgitation in pts with HFrEF, HFmrEF and HFpEF: the good, the bad and the ugly ?
Presentation
Functional mitral regurgitation in pts with HFrEF, HFmrEF and HFpEF: the good, the bad and the ugly ?
Impact of functional mitral regurgitation at discharge upon survival in patients with acute decompensated HFpEF, HFmrEF and HFrEF
Presentation
Impact of functional mitral regurgitation at discharge upon survival in patients with acute decompensated HFpEF, HFmrEF and HFrEF
Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.
Presentation
Differences in VWF activity in von willebrand disease type 2A patients versus LVAD patients with the acquired von willebrand syndrome.
Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.
Presentation
Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.
Prognostic role of myocardial SERPINA3 and ST2 transcripts in predicting mortality in patients with heart failure due to idiopathic cardiomyopathy
Presentation
Prognostic role of myocardial SERPINA3 and ST2 transcripts in predicting mortality in patients with heart failure due to idiopathic cardiomyopathy

ESC 365 is supported by